Latest News and Press Releases

Esperite's biotech company The Cell Factory, Belgium has received funding from the European Union's Horizon 2020 research and innovation Programme for development and characterization of the...

Amsterdam, The Netherlands - 30 April 2018 Esperite regrets to announce that due to technical issues and despite the constant efforts provided by the different teams involved, the publication of...

Continuation of support to Esperite's strategy, commercial activities and development of innovative technologies in the field of genetics and regenerative medicines Amsterdam, The Netherlands -...

Esperite with its biotech company The Cell Factory has acquired from OPBG the full rights to the IP and the international patent family covering the invention and the therapeutic use of the EV's...

Amsterdam, The Netherlands - 2  March 2018 Esperite N.V. (Euronext: ESP, "Esperite" or "the Group") announces that today the  16th Tranche of EUR 250,000 is issued as a private placement of 25...

Continuation of support to Esperite's strategy, commercial activities and development of innovative technologies in the field of genetics and regenerative medicines Amsterdam, The Netherlands -...

Esperite with BGI sequencing technology will enable the global population easier access to the gold standard in clinical genetic testing. Amsterdam, The Netherlands - 31 January 2018 BGI is the...

Amsterdam, The Netherlands - 31 January 2018 Esperite N.V. (Euronext: ESP, "Esperite" or "the Group") announces that today the 14th Tranche of EUR 250,000 is issued as a private placement of 25...

Amsterdam, The Netherlands - 16 January 2018 Esperite N.V. (Euronext: ESP, "Esperite" or "the Group") announces that today the 13th Tranche of EUR 250,000 is issued as a private placement of 25...

                Amsterdam, The Netherlands - 10 January 2018 As Esperite N.V. (Euronext: ESP, "Esperite" or "the Group") is completing its strategy to concentrate its laboratory activities in its...